Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A. Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Diaz, Basil S. Lewis, Harald Darius, Hans-Christoph Diener, Campbell D. Joyner, Lars Wallentin

Open source

DOI: 10.1056/nejmoa0905561
Published: 2009-09-17
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa0905561,
  title = {Dabigatran versus Warfarin in Patients with Atrial Fibrillation},
  author = {Stuart J. Connolly and Michael D. Ezekowitz and Salim Yusuf and John Eikelboom and Jonas Oldgren and Amit Parekh and Janice Pogue and Paul A. Reilly and Ellison Themeles and Jeanne Varrone and Susan Wang and Marco Alings and Denis Xavier and Jun Zhu and Rafael Diaz and Basil S. Lewis and Harald Darius and Hans-Christoph Diener and Campbell D. Joyner and Lars Wallentin},
  year = {2009},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa0905561},
  url = {https://doi.org/10.1056/nejmoa0905561}
}

RIS

TY  - JOUR
TI  - Dabigatran versus Warfarin in Patients with Atrial Fibrillation
AU  - Stuart J. Connolly
AU  - Michael D. Ezekowitz
AU  - Salim Yusuf
AU  - John Eikelboom
AU  - Jonas Oldgren
AU  - Amit Parekh
AU  - Janice Pogue
AU  - Paul A. Reilly
AU  - Ellison Themeles
AU  - Jeanne Varrone
AU  - Susan Wang
AU  - Marco Alings
AU  - Denis Xavier
AU  - Jun Zhu
AU  - Rafael Diaz
AU  - Basil S. Lewis
AU  - Harald Darius
AU  - Hans-Christoph Diener
AU  - Campbell D. Joyner
AU  - Lars Wallentin
PY  - 2009
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa0905561
UR  - https://doi.org/10.1056/nejmoa0905561
ER  -

APA

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., Lewis, B. S., Darius, H., Diener, H., Joyner, C. D., & Wallentin, L. (2009). Dabigatran versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa0905561

Source records

crossref · retrieved 2026-09-25T02:33:39.724Z